
Join us in helping to make healthcare fairer and faster. / Pridružite se nam in nam pomagajte povečati pravičnost in hitrost zdravstvenega varstva.
We are highly motivated and skilled experts, and we are looking for experienced, curious, inspiring Leading Scientist in Early Development, who will support development of Biosimilars.
Your key responsibilities:
What you will bring to the role:
What we offer:
Job location: Mengeš
Contract type: permanent contract with 6-month probation period
Expected weekly working hours: 40
*Pay range: €50,720 – €76,080 gross
* Salary at Sandoz is based on job level, qualifications, specific skills, and work experience. Fully proficient candidates are usually placed around the market median, less experienced candidates lower in the range, and those with strong or niche expertise higher. When determining placement within the range, we also consider internal pay equity and external market data.
Our compensation package additionally includes:
Ready for your next career move?
You are kindly invited to submit your application in English and Slovene, including a CV, by August 9th 2026.
Why Sandoz?
Sandoz is the global leader in Biosimilar and Generic medicines, a segment of the healthcare industry that delivers 80% of the world’s medicines at 30% of the cost, touching the lives of more than 1 billion people across 100+ countries! While we are proud of our achievements, we have the ambition to do more so that everyone can benefit from the basic human right of good health.
With investments in new development capabilities, production sites, new acquisitions and partnerships, we have the opportunity to shape a sustainable future for Sandoz and to help even more people gain access to low-cost, high-quality medicines.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues who, in return for applying their skills, experience an agile and collegiate environment where diversity of thought is welcomed and where personal growth is supported!
Join us in helping to make healthcare fairer and faster.
Commitment to Diversity & Inclusion:
We are committed to building an outstanding, inclusive work environment and to forming diverse teams that are representative of the patients and communities we serve.
#Sandoz
-----------------------------------------------------------------------------------------------------------------------------
Vodilni raziskovalec v Zgodnjem razvoju farmacevtskih izdelkov, oddelek Kemijske znanosti - podobna biološka zdravila (d/ž/m)
Smo ekipa izredno motiviranih in usposobljenih strokovnjakov, ki išče izkušenega, vedoželjnega in navdihujočega sodelavca, za delovno mesto Vodilni raziskovalec v zgodnjem razvoju farmacevtskih izdelkov, ki bo sodeloval pri razvoju podobnih bioloških zdravil.
Vaše ključne odgovornosti:
Vaš doprinos k delovnem mestu:
Kaj nudimo:
* Plača v Sandozu temelji na nivoju delovnega mesta, kvalifikacijah, specifičnih veščinah in znanjih ter delovnih izkušnjah. Visoko usposobljeni kandidati so običajno umeščeni okoli mediane plačnega razpona, manj izkušeni na spodnji del razpona, kandidati z izrazito močnimi ali nišnimi kompetencami pa višje. Pri umeščanju v plačni razpon upoštevamo tudi notranjo uravnoteženost plač in zunanje tržne podatke
Naš paket ugodnosti dodatno vključuje:
Ste pripravljeni na naslednji korak v karieri?
Prijavo z življenjepisom v angleškem in slovenskem jeziku lahko oddate najpozneje do 9. avgusta 2026
Zakaj Sandoz?
Sandoz je vodilni svetovni proizvajalec generičnih in podobnih bioloških zdravil – segmenta zdravstvene industrije, ki zagotavlja 80 % vseh zdravil na svetu po 30-odstotni ceni ter s tem vpliva na življenja več kot milijarde ljudi v več kot 100 državah. Čeprav smo ponosni na svoje dosežke, si prizadevamo narediti še več, da bi vsakdo imel dostop do temeljne človekove pravice – pravice do dobrega zdravja.
Z naložbami v nove razvojne zmogljivosti, proizvodne lokacije, nove pridobitve in partnerstva imamo priložnost oblikovati prihodnost Sandoza ter še večjemu številu ljudi omogočiti trajnostni dostop do cenovno ugodnih in visokokakovostnih zdravil.
Naš zagon temelji na odprti kulturi sodelovanja, katere srce so naši talentirani in ambiciozni sodelavci in sodelavke. V okolju, kjer so raznoliki načini razmišljanja dobrodošli in kjer se podpira osebna rast, imajo v zameno za uporabo svojih znanj možnost v celoti izkusiti delo v agilnem in povezovalnem okolju ter razvijati svojo uspešno kariero.
Pridružite se nam in nam pomagajte povečati pravičnost in hitrost zdravstvenega varstva.
Predani smo raznolikosti in vključenosti:
Zavzemamo se za raznolikost, enake možnosti in vključenost. Prizadevamo si za oblikovanje raznolikih timov, saj ti predstavljajo naše bolnike in skupnosti, ki jih oskrbujemo.
#Sandoz
Skills Desired
Analysis, Analysis, Analytical Chemistry, Analytical Skill, Automated Process, Chemical Analysis, Chemical Laboratory, Chemical Synthesis, Chemistry, Data Analysis, Diversity & Inclusion, Drug Development, Drug Discovery, Emotional Intelligence (EQ), Employee Development, Graph Algorithms, HPLC (High-Performance Liquid Chromatography), Innovation, Innovative Medicines, Machine Learning Algorithms, Medical Research, Medicinal Chemistry, Molecular Biology, Molecular Modelling, Organic Chemistry {+ 9 more}

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc